Issuer % of Class Filed
Schedule 13G · 6 securities · passive
Replimune Group, Inc. 13G/A
REPL · 76029N106
8.7%
Checked 5% or less
8/14/2026
Event 6/30/2026
Lenz Therapeutics, Inc. 13G/A
LENZ · 52635N103
0% 2/17/2026
Event 12/31/2025
Semler Scientific, Inc. 13G/A
SMLR · 81684M104
0% 11/14/2025
Event 9/30/2025
iTeos Therapeutics, Inc. 13G/A
ITOS · 46565G104
0% 11/14/2025
Event 9/30/2025
Affimed N.V. 13G/A
AFMDQ · N01045207
0% 5/20/2025
Event 5/16/2025
Pyxis Oncology, Inc. 13G/A
PYXS · 747324101
0.6% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.